Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations
Giulia Escobar, Marcela V Maus · 2026
Read Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations by Giulia Escobar, Marcela V Maus (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241626.txt.
Description
Giulia Escobar and Marcela V Maus present a 2026 review of combination strategies to make engineered T cell therapy work in pancreatic cancer. This cancer resists immunotherapy through dense scar-like tissue and a suppressive local environment. Engineered cells must enter the tumor and stay active once inside.
The authors discuss their recent preclinical work with cells aimed at mesothelin, a protein found on these tumors. One drug raised target levels on tumor cells by blocking its shedding. Another drug steered T cells toward a more helpful state. Blocking the PD-1 brake restored cell function in tumors carrying its partner protein. Combining such approaches, they argue, beats seeking a single fix.
Catalog record
| CREATOR | Giulia Escobar, Marcela V Maus |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |